Codex @codex  0

A covalent inhibitor developed against KRAS G12C protein, also called sotorasib. Its state-dependent binding illustrates targeting a mutant small GTPase outside the nucleotide site.^[ref]

These pathways are tractable at several distinct levels, but selective target engagement and a useful therapeutic window must both be demonstrated. A G protein-coupled receptor acts as a guanine nucleotide exchange factor for a heterotrimeric G protein: release of GDP permits GTP binding, changing the interactions of both the G protein alpha subunit and Gβγ with effectors. GTPase-activating proteins, including regulators of G protein signalling, accelerate return to the GDP-bound state. Gαs can stimulate adenylyl cyclase, Gαi can inhibit it, and Gαq can activate phospholipase C, linking receptor occupancy to different intracellular responses. The related small GTPases, such as Ras, also alternate between GDP- and GTP-bound states, but are monomeric switches with different activators and effectors. Strategies effective against one family cannot simply be assumed to work against the other.

The receptor is often the most accessible intervention point. An orthosteric antagonist competes with the endogenous ligand; an agonist activates a deficient response, while a partial agonist can produce an intermediate response and antagonize a higher-efficacy agonist. For example, beta-adrenergic receptor blockade reduces adrenergic stimulation of the heart. However, conserved binding pockets make receptor-subtype selectivity difficult, and the same receptor can have useful and harmful functions in different tissues. An allosteric modulator binds elsewhere and changes the affinity or efficacy of the endogenous ligand. This can exploit a less conserved pocket and preserve the timing of endogenous release; it does not automatically confer tissue specificity or a ceiling on toxicity. Structural studies of the beta-2 adrenergic receptor show why stabilizing particular receptor conformations can change coupling rather than merely change occupancy.^[ref]

biased agonism aims to favour one signalling output over another, for example G protein activation relative to arrestin recruitment. An opioid study found that TRV130 combined analgesia with reduced respiratory and gastrointestinal effects in rodent comparisons with morphine.^[ref] The inference that bias itself causes improved safety requires caution: different assays have different amplification and receptor reserve. Later direct measurements showed that low intrinsic G protein efficacy can explain favourable profiles of several proposed biased opioids.^[ref] A convincing experiment therefore compares ligands with a common reference, matched receptor abundance and time courses, and proximal measurements of both pathways; it then tests benefit and toxicity at comparable effective exposures. An arrestin recruitment assay alone cannot predict an entire clinical adverse-effect profile.

Direct inhibition of the switch is also possible. Competing at a nucleotide-binding site is difficult because intracellular nucleotides are abundant and binding is tight. Nevertheless, an alternative pocket can trap a particular state. YM-254890 binds an interdomain cleft of Gαq and inhibits nucleotide exchange by stabilizing the GDP-bound arrangement. Structural analysis, exchange measurements and tests against other G protein families connect binding to mechanism, rather than inferring Gαq inhibition from a fall in a distant calcium response.^[ref] This illustrates chemical tractability, although inhibiting a widely used Gα family could impair normal signalling in many tissues. Targeting an interaction with a particular receptor, exchange factor or effector may give greater contextual selectivity.

A complementary example is covalent inhibition of mutant Ras. AMG 510 exploits a pocket adjacent to cysteine 12 in KRAS G12C and favours the inactive GDP-bound protein. Its mutant-selective chemistry avoids requiring a nucleotide competitor, and biochemical, cellular and animal experiments connected the compound with suppression of signalling and tumour growth.^[ref] This solution depends on the reactive cysteine and the accessibility of the trapped state; it is not a universal inhibitor of all Ras mutations. Exchange activity, pathway feedback, alternative signalling and additional mutations can change sensitivity. Moreover, a monomeric Ras inhibitor is evidence about a broader GTPase strategy, not evidence that all heterotrimeric G proteins have equivalent pockets.

Other possible interventions include blocking selected Gβγ–effector contacts, enhancing a suitable GTPase-activating protein, preventing cell membrane recruitment, or inhibiting a downstream enzyme. Each trades accessibility against specificity: a downstream convergence point can bypass an inaccessible upstream lesion, but may suppress useful signals from many receptors. To select between these strategies, establish the disease-dependent molecular state, measure direct binding and exchange or hydrolysis, and confirm the predicted proximal output. Use an inhibitor-resistant rescue allele, an isogenic target-negative control, and counterscreens against related switches and unrelated cytotoxicity. Follow this with target engagement in the relevant tissue and measurements of normal physiological responses. The strongest therapeutic case combines a drug-accessible pocket or interface with a disease-specific dependence; pathway membership alone is insufficient.

The membrane supplies G proteins with an address, an orienting surface, a reaction environment and a route for spatial redistribution. Its role therefore goes beyond retaining a protein near a receptor. Lipid composition, covalent anchors, membrane organization and trafficking can alter which partners meet, which interfaces are exposed and how long a signal persists.

For a heterotrimeric G protein, an activated G protein-coupled receptor promotes release of GDP from the $\alpha$ subunit and binding of GTP. The nucleotide switch changes interaction with the $\beta \gamma$ complex and downstream effectors; GTP hydrolysis favors termination and reassociation. This is not phosphorylation of GDP by the receptor. Both the $\alpha$ subunit and the $\beta \gamma$ complex can participate in downstream signaling, and their activation need not entail complete physical separation in every receptor–subunit combination. The relevant question is whether the effector-binding surfaces and local interactions change.

Covalent protein lipidation helps place this cycle at a membrane. Many $\alpha$ subunits undergo S-palmitoylation, some also undergo N-myristoylation, and the $\gamma$ subunit commonly undergoes prenylation near its C-terminus. These modifications attach chemically different hydrophobic groups; their distributions depend on the subunit, so no single anchor recipe describes every G protein. Additional basic residues, contacts among subunits and membrane-facing surfaces stabilize association. The membrane anchor on $\gamma$ helps position the whole $\beta \gamma$ complex. Because one attachment can be individually weak or nonspecific, combined signals can determine both residence time and preference for a particular membrane.

small GTPases illustrate the same logic in a distinct signaling architecture. Ras isoforms have a prenylation anchor and additional targeting information. Palmitoylation contributes to targeting of some isoforms, while the polybasic region of KRAS4B promotes interaction with negatively charged inner-leaflet lipids. Reversible acylation and trafficking can therefore change localization without altering the nucleotide-binding core. Mutating an anchoring site should be interpreted with expression, processing and nucleotide-loading controls: an inactive cytosolic mutant does not by itself distinguish loss of a necessary location from a direct catalytic defect.

Membrane tethering can enhance productive encounters by restricting motion to a surface and increasing local availability near a membrane-associated partner. It also sets orientation and limits the orientations accessible to the protein. More surface density does not guarantee faster signaling: trapping in an inappropriate region, unfavorable orientation or crowding can reduce access. A clean experimental comparison is to retarget an anchor-deficient protein with an independent membrane tether, confirming comparable surface density. Rescue would support the importance of localization; failure could indicate the original anchor also specifies orientation, lipid preference or trafficking, or that the replacement tether introduces an artifact.

The membrane can regulate even a correctly localized G protein through contacts with its folded domain. For KRAS4B, NMR spectroscopy on lipid bilayer nanodiscs demonstrated membrane-associated orientations in which an effector-binding surface can be occluded. Some disease-associated mutations changed this interaction and favored effector accessibility.^[ref] Thus a protein can remain attached while its signaling competence changes. The inference is specific to the tested constructs and lipid environments; it does not prove that every Ras isoform or every active state has one universal membrane orientation.

Lipids can also act at the receptor–G protein interface. Phosphatidylinositol 4,5-bisphosphate is a negatively charged inner-leaflet signaling lipid, not simply an inert bulk solvent. Native mass spectrometry and complementary experiments showed that it can stabilize active G protein-coupled receptor complexes and influence G protein coupling selectivity.^[ref] Specific lipid binding, general surface electrostatics and changes in membrane mechanics are competing or cooperating explanations in any new system. Vary the relevant lipid while holding total charge and other physical properties as constant as possible; compare mutations in the candidate binding site with control surface mutations. A bound lipid detected after purification is useful evidence but needs functional corroboration in a lipid bilayer.

Bulk composition further affects hydrophobic mismatch, membrane thickness, local order and the conformational cost of receptor activation. Cholesterol and sphingomyelin can alter the organization of a lipid bilayer; acyl-chain diversity can affect diffusion and anchor partitioning. Distinct membrane nanodomains may enrich some receptors, G proteins and effectors while separating others. These are dynamic, context-dependent organizations. Detergent-resistant extraction does not demonstrate a pre-existing domain of a particular size in a living biological cell, and diffraction-limited colocalization cannot establish molecular interaction. Use live-cell tracking, proximity readouts and controlled membrane reconstitution, with caution that cholesterol depletion also changes many unrelated membrane processes.

The membrane is also a chemical participant downstream. Activation of phospholipase C hydrolyzes phosphatidylinositol 4,5-bisphosphate, producing membrane-retained diacylglycerol and soluble inositol trisphosphate. This both generates distinct signals and changes the abundance of a receptor-associated lipid. Some ion channels are regulated by $\beta \gamma$ and by phosphatidylinositol 4,5-bisphosphate, linking local protein interactions to local lipid availability. Consequently, removing this lipid could impair receptor coupling, an effector, or both. Separate receptor-mediated nucleotide exchange from effector activity in a reconstituted assay before assigning the step affected.

Localization changes in time. Receptor activation can redistribute particular $\beta \gamma$ combinations from the plasma membrane to internal membranes, creating opportunities for signaling at the Golgi apparatus and other sites. Experiments on receptor-induced $\beta \gamma$ movement linked this redistribution to Golgi apparatus structure and secretion.^[ref] Subunit-dependent anchor interactions help determine the kinetics. Receptor trafficking can additionally move signaling platforms to endosomes: conformation-selective antibody probes have detected active beta-2 adrenergic receptors and their G proteins there, with internalized receptors contributing to the cellular response.^[ref] A signal measured from the whole biological cell may therefore persist after its surface component declines. These possibilities require compartment-resolved measurements rather than an assumption that all signaling occurs at the surface.

To separate these roles, reconstitute a receptor and a defined heterotrimeric G protein in lipid bilayer nanodiscs or lipid vesicles of controlled composition, verifying receptor orientation and active fraction. Measure nucleotide exchange, GTP hydrolysis and effector response separately, then compare live-cell localization and signaling biosensors. Quantify expression, anchor processing, membrane integrity and sensor specificity; include rescue of a depleted lipid and an independent method of perturbing the same variable. The same G protein nucleotide state can generate different outputs because membrane attachment, orientation, lipid contacts and compartmental residence determine whether a productive signaling complex can form.

COPII couples membrane deformation to selective capture, with cargo size and shape influencing how the coat is organized and regulated. The coat is not merely a rigid container assembled after sorting. Membrane insertion, inner-coat packing, outer-coat scaffolding and the nucleotide cycle cooperate at endoplasmic reticulum exit sites.

Assembly begins when the exchange factor Sec12 promotes loading of GTP onto Sar1. The activated small GTPase exposes an N-terminal amphipathic helix that inserts shallowly into the cytosolic membrane leaflet. Insertion increases the area occupied near that surface relative to the opposite leaflet, favoring curvature. Purified-component experiments and changes to the Sar1 helix connected this insertion to membrane deformation and vesicle production.^[ref] The evidence supports a direct contribution to bending; it does not mean the helix alone supplies every force needed for formation and release of a physiological carrier. Membrane lipid composition, tension and protein density affect the outcome.

Membrane-bound Sar1 recruits the Sec23-Sec24 complex. Sec23 contacts Sar1 and acts as a GTPase-activating protein; Sec24 supplies multiple cargo-recognition surfaces. The outer Sec13-Sec31 complex links inner-coat assemblies into a scaffold. Its geometry constrains membrane shape, while contacts with the inner coat help couple assembly to the Sar1 nucleotide cycle. Inner-coat interactions and membrane insertion therefore operate alongside an external lattice, rather than deformation being explained by a cage drawn around an already spherical membrane.

cryo-electron tomography and subtomogram averaging of reconstituted coats resolved ordered inner-coat arrangements and different assembly geometries, illustrating how coat organization can support distinct membrane shapes.^[ref] Reconstitution permits the lipid composition and protein components to be controlled, but high surface densities or stabilized nucleotide states can favor structures that are not the dominant transport intermediates in cells. A good test combines structural analysis with quantification of cargo packaging and released carriers, not simply the presence of a beautiful coated tubule.

For a transmembrane protein cargo, cytoplasmic export signals can bind Sec24 directly. Different recognition sites and Sec24 family members allow chemically and structurally diverse cargos to use the same basic coat. Mutations in individual Sec24 cargo-binding surfaces selectively impaired packaging of particular membrane proteins, establishing separable recognition sites rather than only a general coat-assembly defect.^[ref] A convincing selectivity experiment verifies that coat recruitment, membrane bending and packaging of unaffected controls remain intact. Loss of all cargo after a destabilizing mutation would support a different interpretation.

Soluble lumenal cargo cannot contact a cytoplasmic coat directly. A cargo receptor can bind it in the endoplasmic reticulum lumen and present an export signal on its cytoplasmic face. Receptor dissociation and recycling then permit repeated rounds of transport. Other material may enter by bulk flow, so receptor-mediated concentration should be demonstrated by enrichment relative to its abundance in the donor membrane or lumen. Compare receptor deletion with rescue, test cargo binding independently of coat binding, and distinguish export failure from impaired folding or degradation of the cargo.

Selectivity includes exclusion. Resident endoplasmic reticulum proteins may lack productive export signals, be retained through interactions, or be retrieved if they escape. Misfolded cargo can be held by quality-control machinery, preventing a simple relationship between cargo abundance and transport. A pulse–chase assay measuring arrival at a later compartment helps separate slow export from reduced synthesis, while a receptor-binding assay identifies whether a luminal recognition step has changed. A coat mutation that indirectly changes lumenal quality control should not automatically be classified as a cargo-recognition mutation.

Large cargo creates an additional geometrical problem. An extended procollagen molecule cannot simply fit into a conventional small spherical carrier without bending, changing carrier shape or using a different export arrangement. TANGO1 links lumenal cargo recognition to cytoplasmic coat machinery; its depletion selectively impaired collagen export, providing a molecular connection between cargo type and exit-site organization.^[ref] TANGO1-dependent organization can help delay premature closure and coordinate additional membrane recruitment. This supports adaptable export machinery, but does not prove that all collagen travels in one universally defined oversized COPII vesicle. Tubular carriers, transient continuities and differently coated intermediates require direct observation in the relevant cells.

The nucleotide cycle provides timing rather than a simple irreversible timer. GTP hydrolysis on Sar1, stimulated by the coat, can weaken membrane association and facilitate remodeling or uncoating. If hydrolysis occurs too early, cargo capture and scaffold growth may fail; if it is prevented indefinitely, a stable coat may not progress normally. Accessory factors and cargo loading can alter this balance. Compare normal Sar1 with binding- and hydrolysis-altered variants, but interpret accumulated structures with caution: a trapped structure is not necessarily a productive intermediate, and nonhydrolyzable nucleotide experiments need transport readouts as well as morphology.

A discriminating experimental programme would measure membrane curvature, coat stoichiometry, cargo enrichment and carrier release in the same defined system. Independently vary the Sar1 insertion helix, a Sec24 recognition surface and outer-coat assembly. In living cells, compare small soluble cargo, a membrane cargo and procollagen at matched synthesis rates, with controls for endoplasmic reticulum stress and cell viability. Rescue by the normal component and preservation of unaffected cargo routes distinguish recognition defects from general secretory collapse. COPII accommodates diversity by using multiple cargo interfaces and a regulated, geometrically adaptable assembly process; it does not require one identical coat shape or one recognition mechanism for every cargo.

A small GTPase participating in protrusion and polarity in migrating cells.

Ras denotes a family of small GTPases that relay signaling through nucleotide-state-dependent interactions with effectors. Membrane targeting depends on lipid anchors and additional sequence features.

A small GTPase is a relatively small nucleotide-switch protein that cycles between GDP- and GTP-bound states. Ras family proteins illustrate signaling mechanisms distinct from the three-subunit organization of a heterotrimeric G protein.